Ruxolitinib for the treatment of severe alopecia areata
Author:
Funder
The Ranjini and Ajay Poddar Resource Fund
Publisher
Elsevier BV
Subject
Dermatology
Reference5 articles.
1. Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition;Xing;Nat Med,2014
2. Tofacitinib for the treatment of severe alopecia areata and variants: a study of 90 patients;Liu;J Am Acad Dermatol,2017
3. Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata;Kennedy Crispin;JCI Insight,2016
4. Oral ruxolitinib induces hair regrowth in patients with moderate-to-severe alopecia areata;Mackay-Wiggan;JCI Insight,2016
5. Two cases of alopecia areata treated with ruxolitinib: a discussion of ideal dosing and laboratory monitoring;Vandiver;Int J Dermatol,2017
Cited by 33 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Exploring the efficacy of baricitinib in treating alopecia areata after failed Janus kinase inhibitor therapy;JAAD Case Reports;2024-01
2. Janus kinase inhibitors for alopecia areata: A narrative review;Indian Journal of Dermatology, Venereology and Leprology;2023-06-21
3. The evaluation of JAK inhibitors on effect and safety in alopecia areata: a systematic review and meta-analysis of 2018 patients;Frontiers in Immunology;2023-06-02
4. Safety of Janus Kinase inhibitors in Patients with Alopecia Areata: A Systematic Review;Clinical Drug Investigation;2023-05
5. Comparative Efficacy and Safety of Janus Kinase Inhibitors Used in Alopecia Areata: A Systematic Review and Meta-analysis;Acta Dermato-Venereologica;2023-01-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3